← Back to Home
Journal

Regenerative Medicine

Careful background reading on regenerative medicine in Japan, with attention to questions, limits, and physician-led confirmation.

Regenerative Medicine Reading

How Regenerative Medicine Committee Review Works in Japan
Aug 5, 2026

How Regenerative Medicine Committee Review Works in Japan

How does Japan actually review a regenerative medicine treatment plan before it can be offered? Learn what a certified committee (CSCRM or CCRM) checks, what independence and conflict-of-interest concerns exist, and what committee review does — and does not — confirm about a treatment.
Category I, II, and III Regenerative Medicine Explained: How Japan Classifies Cell-Based Medicine
Aug 5, 2026

Category I, II, and III Regenerative Medicine Explained: How Japan Classifies Cell-Based Medicine

Learn how Japan’s regenerative medicine categories (Category I, II, and III) are classified under the Act on the Safety of Regenerative Medicine, including review frameworks, waiting periods, and what regulatory categories do — and do not — mean for patients.
How Platelet-Rich Plasma (PRP) Is Prepared and Used: A Patient-Friendly Explanation
Aug 4, 2026

How Platelet-Rich Plasma (PRP) Is Prepared and Used: A Patient-Friendly Explanation

PRP starts as an ordinary blood draw. Here is what actually happens between that draw and the injection, and what the concentrated platelets are believed to do once administered.
Stem Cell Culture Supernatant, PRP, and Exosomes: What's the Difference in Aesthetic Treatment?
Aug 4, 2026

Stem Cell Culture Supernatant, PRP, and Exosomes: What's the Difference in Aesthetic Treatment?

Three formulation types show up constantly in regenerative aesthetics research and marketing. Here is what actually separates them, and what current evidence does and doesn't support.
Where Do Your Cells Go? A Patient-Friendly Explanation of Collection, Processing, and Administration
Aug 1, 2026

Where Do Your Cells Go? A Patient-Friendly Explanation of Collection, Processing, and Administration

For autologous stem cell therapy, your cells go through collection, weeks of culture and purification, quality testing, and administration — here's what each stage actually involves.
What "MHLW-Recognized" or "Regulatory Plan Number" Actually Means in Japan
Aug 1, 2026

What "MHLW-Recognized" or "Regulatory Plan Number" Actually Means in Japan

"MHLW-recognized" isn't an official certification a clinic receives — it's shorthand for a specific legal filing process. Here's what that process actually covers, and what it doesn't.
Is Stem Cell Therapy in Japan Safe? What to Know
Aug 1, 2026

Is Stem Cell Therapy in Japan Safe? What to Know

Stem cell therapy in Japan operates within a specific legal safety framework, with screening, clean-room cell processing, and physician-led review — here's what that framework actually covers, and what it doesn't guarantee.
More from the Journal
Private Case Review

Let us understand the case before anyone recommends a plan.

Share your goals, medical background, and travel window. StemCellor will help organize the next step around physician review, realistic expectations, timing, and reference cost.

Direct messaging channels are still being confirmed — for now, start through the international patient guide.

A private review table with a tea cup, closed folio, and folded documents in a quiet Japanese interior
Prepare an Inquiry
01
Share your background

Send the main concern, treatment goals, and any medical history that may affect candidacy.

02
Review the right pathway

We help clarify which treatment area may be worth discussing before travel is planned.

03
Coordinate the next step

When appropriate, the case is prepared for physician review and visit planning in Japan.

Open consultation chat